|
|
|
|
Дата |
|---|
| 16.03.2026 |
| 15.03.2026 |
| 12.03.2026 |
| 11.03.2026 |
| 10.03.2026 |
| 09.03.2026 |
| 08.03.2026 |
| 05.03.2026 |
| 04.03.2026 |
| 03.03.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
61.89
|
60.11
|
62.10
|
60.97
|
|
|
658 716.46
|
114.00
|
|
|
|
61.89
|
61.50
|
62.18
|
61.89
|
|
|
262 572.09
|
54.00
|
|
|
|
62.32
|
61.00
|
63.10
|
61.89
|
|
|
627 628.85
|
100.00
|
|
|
|
61.79
|
61.50
|
63.10
|
62.32
|
|
|
792 698.02
|
109.00
|
|
|
|
60.50
|
60.51
|
62.39
|
61.79
|
|
|
2 119 485.71
|
179.00
|
|
|
|
60.85
|
60.00
|
60.93
|
60.50
|
|
|
731 510.70
|
118.00
|
|
|
|
60.28
|
60.00
|
60.99
|
60.85
|
|
|
1 128 038.08
|
171.00
|
|
|
|
59.40
|
59.25
|
61.00
|
60.28
|
|
|
954 774.88
|
130.00
|
|
|
|
59.70
|
59.10
|
61.00
|
59.40
|
|
|
755 716.70
|
163.00
|
|
|
|
59.29
|
59.01
|
60.38
|
59.70
|
|
|
1 387 279.48
|
152.00
|
Период |
|---|
| 2025, регулярные |
| 2022, регулярные |
| 2022, регулярные |
| 2019, регулярные |
| 2018, регулярные |
| 2016, регулярные |
| 2015, регулярные |
| 2014, регулярные |
| 2011, регулярные |
| 2010, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
08.01.2026
|
11.01.2026 |
1 EGP |
|
25.06.2023
|
03.07.2023 |
0.75 EGP |
|
02.01.2023
|
03.01.2023 |
3 EGP |
|
28.08.2020
|
31.08.2020 |
0.5 EGP |
|
01.12.2019
|
02.12.2019 |
0.5 EGP |
|
24.12.2017
|
25.12.2017 |
0.5 EGP |
|
11.11.2016
|
14.11.2016 |
0.5 EGP |
|
08.07.2015
|
09.07.2015 |
0.5 EGP |
|
24.05.2012
|
27.05.2012 |
0.75 EGP |
|
03.06.2011
|
06.06.2011 |
0.75 EGP |
GlaxoSmithKline SAE, a member of Glaxo Group Limited (Britain), is an Egypt-based company engaged in manufacturing, packaging, marketing, sale and distribution of pharmaceutical products.
